Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/29/25 17:04 | 1/27/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Bhatt Padmanabh P. | MD | O | SVP of I | 8 | S.dm | -4,264 | 34.59 | 0 | -123 | 10 | D | |||||||||||||||
11/12/24 16:15 | 11/11/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Newhall Charles W III | MD | D | 2 | S.d | -458 | 34.68 | 0 | -13 | 130 | D | ||||||||||||||||
11/12/24 16:14 | 11/8/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Hudson Frederick M. | MD | D | 2 | S.d | -576 | 32.31 | 0 | -18 | 33 | D | ||||||||||||||||
11/12/24 16:13 | 11/8/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Gemayel Georges | MD | D | 3 | S.d | -1,347 | 34.64 | 0 | -39 | 13 | D | ||||||||||||||||
11/12/24 16:11 | 11/8/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Khattar Jack A. | MD | DO | P,CEO | 2 | S.d | -9,121 | 36.49 | 0 | -250 | 1,949 | D | |||||||||||||||
11/8/24 16:13 | 11/7/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Mottola Frank | MD | O | SVP,Qual | 2 | S.d | -586 | 36.37 | 0 | -16 | 8 | D | |||||||||||||||
1/12/24 17:00 | 1/10/24 | SUPN | Health | Drug | Pharmaceutical Preparations | Martin Tami Tillotson | MD | O | SVP,Regu | 1 | S.d | -223 | 27.91 | 0 | -8 | 86 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |